The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
MyD88: a central player in innate immune signaling
Open accessAbstract
MyD88 is the canonical adaptor for inflammatory signaling pathways downstream of members of the Toll-like receptor (TLR) and interleukin-1 (IL-1) receptor families. MyD88 links IL-1 receptor (IL-1R) or TLR family members to IL-1R-associated kinase (IRAK) family kinases via homotypic protein-protein interaction. Activation of IRAK family kinases leads to a variety of functional outputs, including the activation of nuclear factor-kappa B (NFκB), mitogen-activated protein kinases, and activator protein 1, making MyD88 a central node of inflammatory pathways. As more details of MyD88-dependent signaling have been elucidated, it has become clear that the functions of this critical signaling component can be influenced by multiple interaction partners in distinct subcellular compartments. In this review, we will focus on recent developments in the understanding of the assembly of MyD88 signaling complexes and the mechanisms leading to the diversification of MyD88-based signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deguine and Barton have shown that the nature of the TLR9 response-IFN type I or pro-inflammatory cytokine production is dependent on the class of CpG motif (class A or B) and the composition of phospholipids in the membrane incorporating TLR9.”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [89]
In the citing paper
“It has also been demonstrated that the pro-inflammatory cytokine response requires a localization motif in the tail of TLR9 while the anti-inflammatory IFN type I response, by contrast, requires the AP-3 adaptor [89].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,286
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. Μ. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,598
Unresponsiveness of MyD88-deficient mice to endotoxin.
Kawai, T., Adachi, O., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80086-2 · Cited by 2,367
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,358
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.
Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C.-Q., Ghosh, S., & Janeway, C. (1998) · Molecules and Cells · doi:10.1016/s1097-2765(00)80136-7 · Cited by 1,783
Oncogenically active MYD88 mutations in human lymphoma
Ngo, V. N., Young, R. M., Schmitz, R., Jhavar, S. G., Xiao, W., Lim, K., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., et al. (2010) · Nature · doi:10.1038/nature09671 · Cited by 1,560
Akira, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300028200 · Cited by 1,499
Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide
Jin, M. S., Kim, S. E., Heo, J. Y., Lee, M. E., Kim, H. M., Paik, S., Lee, H., & Lee, J. (2007) · Cell · doi:10.1016/j.cell.2007.09.008 · Cited by 1,391
Toll-like receptors control activation of adaptive immune responses
Schnare, M., Barton, G. M., Czopik, A. K., Takeda, K., Akira, S., & Medzhitov, R. M. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,364
Self-citationTRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β
Kagan, J. C., Su, T., Horng, T., Chow, A. Y., Akira, S., & Medzhitov, R. M. (2008) · Nature Immunology · doi:10.1038/ni1569 · Cited by 1,310
Cited by
Sorted by citations
Items 101–200 of 687
CCN1 is an opsonin for bacterial clearance and a direct activator of Toll-like receptor signaling
Jun, J.-I., & Lau, L. F. (2020) · Nature Communications · doi:10.1038/s41467-020-15075-5 · Cited by 55
Pinto, S. M., Kim, H., Subbannayya, Y., Giambelluca, M. S., Bösl, K., Ryan, L., Sharma, A., & Kandasamy, R. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.679458 · Cited by 59
Marques, O., Horvat, N. K., Zechner, L., Colucci, S., Sparla, R., Zimmermann, S., Neufeldt, C. J., Altamura, S., Qiu, R., Müdder, K., et al. (2024) · Blood · doi:10.1182/blood.2023023417 · Cited by 55
Brandquist, N. D., & Kielian, T. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00782-y · Cited by 57
Innate Immune Recognition: An Issue More Complex Than Expected
Kubelková, K., & Macela, A. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00241 · Cited by 55
Acetylation of TIR domains in the TLR4-Mal-MyD88 complex regulates immune responses in sepsis
Li, X., Li, X., Huang, P., Zhang, F., Du, J. K., Kong, Y., Shao, Z., Wu, X., Fan, W., Tao, H., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00237-8 · Cited by 52
Stimulus-specific responses in innate immunity: Multilayered regulatory circuits
Luecke, S., Sheu, K. M., & Hoffmann, A. (2021) · Immunity · doi:10.1016/j.immuni.2021.08.018 · Cited by 52
Modulation of Toll-like receptor signaling in innate immunity by natural products
Chen, L., & Yu, J. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.02.005 · Cited by 51
TLR-Mediated Signal Transduction and Neurodegenerative Disorders
Adhikarla, S. V., Jha, N. K., Goswami, V. K., Sharma, A., Bhardwaj, A., Dey, A., Villa, C., Kumar, Y., & Jha, S. K. (2021) · Brain Sciences · doi:10.3390/brainsci11111373 · Cited by 50
Liang, W., Zeng, X., Jiang, S., Tan, H., Yan, M.-Y., & Yang, H. (2019) · Cell Biology International · doi:10.1002/cbin.11235 · Cited by 50
The STING1-MYD88 complex drives ACOD1/IRG1 expression and function in lethal innate immunity
Chen, F., Wu, R., Liu, J., Kang, R., Li, J., & Tang, D. (2022) · iScience · doi:10.1016/j.isci.2022.104561 · Cited by 50
TLR4 signaling induces TLR3 up-regulation in alveolar macrophages during acute lung injury
Ding, X., Jin, S., Tong, Y., Jiang, X., Chen, Z., Mei, S., Zhang, L., Billiar, T. R., & Li, Q. (2017) · Scientific Reports · doi:10.1038/srep34278 · Cited by 51
Jin, J., Lv, X., Wang, B., Ren, C., Jiang, J., Chen, H., Chen, X., Gu, M., Pan, Z., Tian, N., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7292512 · Cited by 50
Wang, T., Hao, Z., Liu, C., Yuan, L., Li, L., Yin, M., Li, Q., Qi, Z., & Wang, Z. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02769-3 · Cited by 49
Syk-MyD88 Axis Is a Critical Determinant of Inflammatory-Response in Activated Macrophages
Yi, Y., Kim, H. G., Kim, J. H., Yang, W. S., Kim, E., Jeong, D., Park, J. G., Aziz, N., Kim, S., Parameswaran, N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767366 · Cited by 50
Innate immune regulations and various siRNA modalities
Kaushal, A. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01361-4 · Cited by 52
E3 ubiquitin ligases, the powerful modulator of innate antiviral immunity
Zheng, Y., & Gao, C. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.04.003 · Cited by 50
Hughes, H. K., Rowland, M. E., Onore, C. E., Rogers, S. J., Ciernia, A. V., & Ashwood, P. (2022) · Translational Psychiatry · doi:10.1038/s41398-021-01766-0 · Cited by 51
Ha, J. Y., Seok, J., Kim, S., Jung, H.-J., Ryu, K., Nakamura, M., Jang, I., Hong, S., Lee, Y., & Lee, H. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011743 · Cited by 49
Chen, Z., Su, L., Xu, Q., Katz, J., Michalek, S. M., Fan, M., Feng, X., & Zhang, P. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.663518 · Cited by 48
Feng, R., Adeniran, S. O., Huang, F., Li, Y., Ma, M., Zheng, P., & Zhang, G. (2021) · Theriogenology · doi:10.1016/j.theriogenology.2021.11.020 · Cited by 46
Li, J.-M., Yao, Y.-D., Luo, J.-F., Liu, J.-X., Lu, L., Liu, Z., Dong, Y., Xie, Y., & Zhou, H. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155114 · Cited by 46
Neuroinflammaging: A Tight Line Between Normal Aging and Age-Related Neurodegenerative Disorders
Soraci, L., Corsonello, A., Paparazzo, E., Montesanto, A., Piacenza, F., Olivieri, F., Gambuzza, M. E., Savedra, E. V., Marino, S., Lattanzio, F., et al. (2024) · Aging and Disease · doi:10.14336/ad.2023.1001 · Cited by 49
Short, K. K., Miller, S. M., Walsh, L. M., Cybulski, V., Bazin, H. G., Evans, J. T., & Burkhart, D. J. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.025 · Cited by 46
Sindhu, S. T. A. K., Kochumon, S., Thomas, R., Bennakhi, A., Al‐Mulla, F., & Ahmad, R. (2020) · Cells · doi:10.3390/cells9030730 · Cited by 46
SPOP promotes ubiquitination and degradation of MyD88 to suppress the innate immune response
Li, Q., Wang, F., Wang, Q., Zhang, N., Zheng, J., Zheng, M., Liu, R., Cui, H., Wen, J., & Zhao, G. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008188 · Cited by 47
Irisin Protects Brain against Ischemia/Reperfusion Injury through Suppressing TLR4/MyD88 Pathway
Yu, Q., Li, G., Ding, Q., Lei, T., Li, J., Sun, L., Sun, X., & Yang, Y. (2020) · Cerebrovascular Diseases · doi:10.1159/000505961 · Cited by 47
IL-38 in modulating hyperlipidemia and its related cardiovascular diseases
Lai, M., Peng, H., Wu, X., Chen, X., Wang, B., & Su, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108876 · Cited by 47
Insight into the role of macrophages in periodontitis restoration and development
Mo, K., Wang, Y., Lu, C., & Li, Z. (2024) · Virulence · doi:10.1080/21505594.2024.2427234 · Cited by 45
Nanjappa, S. G., Hernández‐Santos, N., Galles, K., Wüthrich, M., Suresh, M., & Klein, B. S. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005161 · Cited by 44
Raju (2005) · doi:10.3389/fvets.2021.640968 · Cited by 42
Yang, Y., Zhou, X., Jia, G., Li, T., Li, Y., Zhao, R., & Wang, Y. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106999 · Cited by 42
Buzzo, C. D. L., Medina, T. D. S., Branco, L. M., Lage, S. L., Ferreira, L. C. D. S., Amarante-Mendes, G. P., Hottiger, M. O., Carvalho, D. D. D., & Bortoluci, K. R. (2017) · Scientific Reports · doi:10.1038/srep41686 · Cited by 44
Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades
Wirsdörfer, F., & Jendrossek, V. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0865-1 · Cited by 43
Microbiome modulates intestinal homeostasis against inflammatory diseases
Sun, X., & Jia, Z. (2018) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2018.10.014 · Cited by 44
Neutralization of pro‐inflammatory monocytes by targeting TLR2 dimerization ameliorates colitis
Shmuel-Galia, L., Aychek, T., Fink, A., Porat, Z., Zarmi, B., Bernshtein, B., Brenner, O. J., Jung, S., & Shai, Y. (2016) · The EMBO Journal · doi:10.15252/embj.201592649 · Cited by 41
Winkler, H. C., Kornprobst, J., Wick, P., von Moos, L. M. E., Trantakis, I. A., Schraner, E. M., Bathke, B., Hochrein, H., Suter, M., & Naegeli, H. (2017) · Particle and Fibre Toxicology · doi:10.1186/s12989-017-0202-8 · Cited by 41
Liu, Z., Han, C., Dong, C., Shen, A., Hsu, E. J., Ren, Z., Lu, C., Liu, L., Zhang, A., Timmerman, C., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aav6473 · Cited by 41
Damour, A., Robin, B., Deroche, L., Broutin, L., Bellin, N., Verdon, J., Lina, G., Leclère, F. M., Garcia, M., Cremniter, J., et al. (2021) · Virulence · doi:10.1080/21505594.2021.1975909 · Cited by 44
Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1β release
Bockstiegel, J., Wurnig, S. L., Engelhardt, J., Enns, J., Hansen, F. K., & Weindl, G. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115693 · Cited by 40
Amer, L. D., Saleh, L. S., Walker, C. J., Thomas, S. M., Janssen, W. J., Alper, S., & Bryant, S. J. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.09.043 · Cited by 42
The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity
He, Y., Vlaming, M., van Meerten, T., & Bremer, E. (2022) · Cancers · doi:10.3390/cancers14020299 · Cited by 40
Irisin, Exercise, and COVID-19
Alves, H. R., Lomba, G. S. B., Gonçalves-de-Albuquerque, C. F., & Burth, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.879066 · Cited by 41
McCarthy, M. K., Reynoso, G. V., Winkler, E. S., Mack, M., Diamond, M., Hickman, H. D., & Morrison, T. E. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008292 · Cited by 39
Kuriakose, S. M., Onyilagha, C., Singh, R. V., Olayinka‐Adefemi, F., Jia, P., & Uzonna, J. E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02673 · Cited by 38
Contreras, M., Pacheco, I., Alberdi, P., Sanchez, S. D., Artigas-Jerónimo, S., Mateos‐Hernández, L., Villar, M., Cabezas‐Cruz, A., & de la Fuente, J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00078 · Cited by 38
Distinct non‐coding RNA cargo of extracellular vesicles from M1 and M2 human primary macrophages
Pantazi, P., Clements, T., Venø, M. T., Abrahams, V. M., & Holder, B. S. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12293 · Cited by 38
Montorsi, M., Pucci, C., Pasquale, D. D., Marino, A., Ceccarelli, M. C., Mazzuferi, M., Bartolucci, M., Petretto, A., Prato, M., Debellis, D., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304331 · Cited by 38
Role of Signaling Molecules in Mitochondrial Stress Response
Hill, S., Sataranatarajan, K., & Remmen, H. V. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00225 · Cited by 39
Anti-inflammatory action of cysteine derivative S-1-propenylcysteine by inducing MyD88 degradation
Suzuki, J., Kodera, Y., Miki, S., Ushijima, M., Takashima, M., Matsutomo, T., & Morihara, N. (2018) · Scientific Reports · doi:10.1038/s41598-018-32431-0 · Cited by 37
Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy
Starosta, A., & Konieczny, P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03821-x · Cited by 41
MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies
Alcoceba, M., García‐Álvarez, M., Medina, A., Maldonado, R., González‐Calle, V., Chillón, C., Sarasquete, M. E., González, M., García‐Sánz, R., & Jiménez, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105570 · Cited by 37
The Effect of Enteric-Derived Lipopolysaccharides on Obesity
Wang, K., Lai, W., Min, T., Wei, J., Bai, Y., Cao, H., Guo, J., & Su, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084305 · Cited by 38
Inflammation accelerating intestinal fibrosis: from mechanism to clinic
Xin, S., Liu, X., He, C., Gao, H., Wang, B., Hua, R., Gao, L., Shang, H., Sun, F., & Xu, J. (2024) · European journal of medical research · doi:10.1186/s40001-024-01932-2 · Cited by 36
Toll-like receptor 3 modulates the behavioral effects of cocaine in mice
Zhu, R., Bu, Q., Fu, D., Shao, X., Jiang, L., Guo, W., Chen, B., Liu, B., Hu, Z., Tian, J., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1130-8 · Cited by 36
Lisco, G., Tullio, A. D., Giagulli, V. A., Guastamacchia, E., Pergola, G. D., & Triggiani, V. (2020) · Endocrine · doi:10.1007/s12020-020-02444-9 · Cited by 37
Muhammad, I., Contes, K. M., Bility, M. T., & Tang, Q. (2025) · Viruses · doi:10.3390/v17040528 · Cited by 38
The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology
Orlacchio, A., & Mazzone, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312743 · Cited by 34
T-Cell MyD88 Is a Novel Regulator of Cardiac Fibrosis Through Modulation of T-Cell Activation
Bayer, A. L., Smolgovsky, S. A., Ngwenyama, N., Hernández-Martínez, A., Kaur, K., Sulka, K. B., Amrute, J., Aronovitz, M. J., Lavine, K. J., Sharma, S., et al. (2023) · Circulation Research · doi:10.1161/circresaha.123.323030 · Cited by 33
Innate immune adaptor MyD88 deficiency prevents skin inflammation in SHARPIN-deficient mice
Sharma, B. R., Karki, R., Lee, E., Zhu, Q., Gurung, P., & Kanneganti, T. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0159-7 · Cited by 33
Immunomodulatory role of the extracellular matrix protein tenascin-C in neuroinflammation
Wiemann, S., Reinhard, J., & Faissner, A. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190081 · Cited by 34
Antibiotics, Inflammation, and Preterm Labor: A Missed Conclusion
Hantoushzadeh, S., Aliabad, R. A., & Norooznezhad, A. H. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s248382 · Cited by 33
Mangge, H., Prüller, F., Schnedl, W. J., Renner, W., & Almer, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114082 · Cited by 33
Mullane, K., & Williams, M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.027 · Cited by 32
Thapa, R., Magar, A. T., Shrestha, J., Panth, N., Idrees, S., Sadaf, T., Bashyal, S., Elwakil, B. H., Sugandhi, V. V., Rojekar, S. V., et al. (2024) · MedComm · doi:10.1002/mco2.70018 · Cited by 33
Immunopathogenesis of Craniotomy Infection and Niche-Specific Immune Responses to Biofilm
de Morais, S. D. B., Kak, G., Menousek, J. P., & Kielian, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.625467 · Cited by 34
Yang, X., Dang, X., Zhang, X., & Zhao, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108283 · Cited by 32
Huang, A., Ji, L., Huang, Y., Yu, Q., & Li, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108508 · Cited by 32
Fan, H., Chen, Z., Tang, H., Shan, L., Chen, Z., Liu, S.-C., Zhang, Y., Guo, X., Yang, H., & Hao, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.994307 · Cited by 32
Lopez, E. M., Leclerc, K., Ramsukh, M., Parente, P. E., Patel, K., Aranda, C. J., Josephson, A. M., Remark, L. H., Kirby, D. J., Buchalter, D. B., et al. (2022) · Bone · doi:10.1016/j.bone.2021.116324 · Cited by 31
Starska, K. (2023) · Nutrients · doi:10.3390/nu15112592 · Cited by 31
MyD88 and Its Inhibitors in Cancer: Prospects and Challenges
Song, J., Li, Y., Wu, K., Hu, Y., & Fang, L. (2024) · Biomolecules · doi:10.3390/biom14050562 · Cited by 31
Giriwono, P. E., Shirakawa, H., Ohsaki, Y., Sato, A., Aoyama, Y., Ho, H., Gotō, T., & Komai, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092320 · Cited by 31
Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis
Fan, Y., Li, Y., Chu, Y., Liu, J., Cui, L., & Zhang, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.608498 · Cited by 31
Fine-tuning of antiviral innate immunity by ubiquitination
Zheng, Y., & Gao, C. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.11.004 · Cited by 31
Kochumon, S., Arefanian, H., Azim, R., Shenouda, S., JACOB, T. K., ABUKHALAF, N. A., Al‐Rashed, F., Hasan, A., Sindhu, S. T. A. K., Al‐Mulla, F., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8100403 · Cited by 30
Emerging diagnostic tests for vitreoretinal lymphoma: a review
Dawson, A. C., Williams, K. A., Appukuttan, B., & Smith, J. R. (2018) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13304 · Cited by 30
Inactivation of the tyrosine phosphatase SHP-2 drives vascular dysfunction in Sepsis
Heun, Y., Pircher, J., Czermak, T., Blüm, P., Hupel, G., Bohmer, M. J., Kraemer, B. F., Pogoda, K., Pfeifer, A., Woernle, M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.034 · Cited by 30
Chen, Y.-H., Yang, M., Zhang, M., Wang, H., Zheng, Y., Sun, R., & Li, X. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320188 · Cited by 29
Ma, B., Yang, Y., Li, Z., Zhao, D., Zhang, W., Jiang, Y., & Xue, D. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9486 · Cited by 29
Primary vitreoretinal lymphoma
Takhar, J. S., Doan, T. A., & Gonzales, J. A. (2019) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000620 · Cited by 29
Evolutionary and functional analysis of MyD88 genes in pearl oyster Pinctada fucata martensii
Jiao, Y., Gu, Z., Luo, S., & Deng, Y. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.02.018 · Cited by 29
Ramírez-Pérez, S., Hernández-Palma, L. A., Oregon‐Romero, E., Anaya-Macías, B. U., García‐Arellano, S., González-Estévez, G., & Muñóz-Valle, J. F. (2020) · Molecules · doi:10.3390/molecules25184322 · Cited by 30
Noda, M., Danshiitsoodol, N., Kanno, K., Uchida, T., & Sugiyama, M. (2021) · Microorganisms · doi:10.3390/microorganisms9112243 · Cited by 29
Xie, L., Zhang, Z., Wang, Q., Chen, Y., Lu, D., & Wu, W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.772865 · Cited by 30
Azar, Y. O., Badawi, G. A., Zaki, H. F., & Ibrahim, S. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121049 · Cited by 29
Cannova, J., Breslin, P., & Zhang, J. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0412-0 · Cited by 29
Noda, M., Sultana, N., Hayashi, I., Fukamachi, M., & Sugiyama, M. (2019) · Molecules · doi:10.3390/molecules24162970 · Cited by 29
Gardiner, J. H., Komazin, G., Matsuo, M., Cole, K., Götz, F., & Meredith, T. C. (2020) · mBio · doi:10.1128/mbio.01619-20 · Cited by 29
Barratt, D. T., Klepstad, P., Dale, O., Kaasa, S., & Somogyi, A. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137179 · Cited by 29
Molecular mechanisms underlying cyclophosphamide-induced ovarian injury and protective strategies
Sharata, E. E., Bakry, T., Atta, H. G., Mohammed, H. A., Diab, N. S., Atef, R. A., Hosney, R. S., Omar, M. M., & Hemeida, R. A. M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04550-9 · Cited by 31
Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us
Kumar, V. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1800688 · Cited by 29
Luo, Y., Zhang, X., Chen, R., Li, R., Liu, Y., Zhang, J., Liu, Q., Si, M., Liu, J., Wu, B., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00858-z · Cited by 28
Li, F., Gong, X., Zhou, Y., Geng, Q., Jiang, Y., Lin, Y., Qu, M., & Tan, Z. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170341 · Cited by 30
Mechanism of MyD88S mediated signal termination
Pustelny, K., Kuska, K., Górecki, A., Musielak, B., Dobosz, E., Wladyka, B., Kozieł, J., Czarna, A., Holak, T., & Dubin, G. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-021-00811-1 · Cited by 27
Molecular mechanisms of aflatoxin neurotoxicity and potential neuroprotective agents
Dai, C., Tian, E., Li, H., Gupta, S., Hao, Z., Wang, Z., Velkov, T., & Shen, J. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250201 · Cited by 30
Goritzka, M., Pereira, C., Makris, S., Durant, L. R., & Johansson, C. (2015) · Scientific Reports · doi:10.1038/srep18533 · Cited by 27
Role of MyD88 in IL-1β and Ethanol Modulation of GABAergic Transmission in the Central Amygdala
Bajo, M., Patel, R. R., Hedges, D. M., Varodayan, F. P., Vlkolinský, R., Davis, T. D., Burkart, M. D., Blednov, Y. A., & Roberto, M. (2019) · Brain Sciences · doi:10.3390/brainsci9120361 · Cited by 27
Yang, S., Yu, Z., Yuan, T., Wang, L., Wang, X., Yang, H., Sun, L., Wang, Y., & Du, G. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.08.041 · Cited by 27
Exosomes from EV71‐infected oral epithelial cells can transfer miR‐30a to promote EV71 infection
Wang, Y., Zhang, S., Song, W., Zhang, W., Li, J., Li, C., Qiu, Y., Fang, Y., Jiang, Q., Li, X., et al. (2020) · Oral Diseases · doi:10.1111/odi.13283 · Cited by 27
Metadata
- Authors
- Deguine, J., & Barton, G. M.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Deguine, Jacques
- Barton, Gregory M.
- Venue
- F1000Prime Reports
- Publisher
- H1 Connect
- Published
- 2014-11-04
- Volume
- 6
- Pages
- 97-97
- ISSN
- 2051-7599 (ISSN-L)
- PMC
- PMC4229726
- OpenAlex
- W2158738222
- Cited by
- 692
- References
- 66
- Citations by year
- 2026: 50 · 2025: 86 · 2024: 104 · 2023: 91 · 2022: 80 · 2021: 85 · 2020: 60 · 2019: 56 · 2018: 30 · 2017: 18 · 2016: 18 · 2015: 14
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- F1000Prime Reports (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Lupus Research Institute
- Lupus Research Alliance
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- MyD88, Toll-like receptors, interleukin-1 receptor, innate immune signaling, NF-κB activation, MAPK signaling, activator protein-1, signaling complex assembly, protein-protein interaction, subcellular compartmentalization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review